Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (521-530 of 666) with videos related to

Pageof 67
Sort By:
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2022
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trialA Dal Pra, P Ghadjar, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approachesA M Udager, T-Y Liu, S L Skala, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Pageof 67

Showing results (521-530 of 666) with videos related to

Sort By:
Pageof 67
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2022
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trialA Dal Pra, P Ghadjar, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approachesA M Udager, T-Y Liu, S L Skala, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Pageof 67